All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status-Reference-Cited by-同舟云学术

All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status

Published:2021-06 Issue:3 Volume:41 Page:491-497
ISSN:2096-5230
Container-title:Current Medical Science
language:en
Short-container-title:CURR MED SCI

Author:

Xu Lin-wei,Su Yong-zhong,Tao Hong-fang

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s11596-021-2377-3.pdf

Reference35 articles.

1. Grignani F, Ferrucci PF, Testa U, et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell, 1993,74(3): 423–431

2. Iland H, Bradstock K, Seymour J, et al. Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia. Haematologica, 2012,97(2):227–234

3. Kayser S, Rahmé R, Martínez-Cuadrón D, et al. Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia, 2020,34(9):2333–2341

4. Breccia M, Loglisci G, Loglisci MG, et al. FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis. Haematology, 2013,98(12): e161–e163

5. Sanz J, Labopin M, Sanz MA, et al. Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission. Bone Marrow Transplant, 2020. doi: https://doi.org/10.1038/s41409-020-01162-0

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF;Blood and Lymphatic Cancer: Targets and Therapy;2024-07

2. Clinical analysis of 82 cases of acute promyelocytic leukemia with PML-RARα short isoform in children and adults;Frontiers in Oncology;2024-02-21

3. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications;Cell Death Discovery;2023-07-27

4. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity;Future Pharmacology;2023-02-01